高流量鼻カニューレ市場の2030年までの予測：部品別、販売チャネル別、用途別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、高流量鼻カニューレの世界市場は2023年に77億米ドルを占め、予測期間中にCAGR 14％で成長し、2030年には192億7,000万米ドルに達する見込みです。

高流量鼻カニューレは、加熱・加湿された酸素を高流量で小さな鼻プロングから供給する呼吸療法機器です。この療法は、急性呼吸不全患者の治療に使用され、快適さを提供し呼吸作業を軽減しながら、正確な酸素化レベルを提供します。加温・加湿された混合ガスは患者の忍容性と可動性を高め、高流量は開口した気道を確保し、気道抵抗を減少させ、侵襲的な機械的換気の必要性を減少させる可能性があります。

世界保健機関（WHO）によると、世界中で2億3,500万人が喘息を患っていると推定されています。

呼吸器疾患の有病率の増加

慢性閉塞性肺疾患（COPD）、喘息、急性呼吸窮迫症候群（ARDS）などの呼吸器疾患は、世界的に増加傾向にあります。これらの疾患では、呼吸困難を緩和し、患者の転帰を改善するために、しばしば効果的な酸素療法が必要とされます。高流量鼻腔カニューレは、従来の酸素療法方法と比較してより高い流量の酸素を供給するため、呼吸器疾患の患者にとって特に有益です。さらに、一定かつ調節可能な酸素供給を提供するため、十分な酸素化が確保され、患者の呼吸器系への負担が軽減されます。

高コスト

HFNCシステムは、従来の酸素療法に比べ比較的高価であるため、ヘルスケア提供者にとって経済的な課題となりうる。流量発生装置と加熱加湿器を含むHFNCシステムの購入に必要な初期投資は、かなりの額になる可能性があります。機器の定期的なメンテナンスと較正の必要性がさらに経済的負担を増やし、ひいては市場の成長を制限しています。

技術の進歩

HFNC技術における継続的な技術革新と改良は、その性能、安全性、患者の快適性を向上させ、導入と利用を増加させる原動力となっています。流量発生器、加熱加湿器、鼻カニューレの設計における革新は、HFNC療法の性能と快適性を向上させています。さらにメーカー各社は、患者の快適性を高め、皮膚刺激を軽減する、柔らかく柔軟で解剖学的な輪郭を持つ鼻カニューレを発表しています。カニューレ設計におけるこれらの進歩は、より良い酸素供給にも貢献し、鼻腔外傷のリスクを軽減します。

代替呼吸補助療法との競合

高流量鼻カニューレ（HFNC）市場は、代替呼吸補助療法との競合による抑制要因に直面しています。二段階気道陽圧（BiPAP）や持続的気道陽圧（CPAP）などの装置を通して行われる非侵襲的人工呼吸は、呼吸不全患者の呼吸を補助するために様々なレベルの圧力サポートを提供します。さらに、重度の呼吸困難や急性呼吸不全の患者には、気管挿管や人工呼吸器によるサポートを含む侵襲的な機械的換気が必要となることが多いです。

COVID-19の影響

COVID-19の大流行は、重症の呼吸器症状、特にCOVID-19に関連した呼吸困難に苦しむ患者を治療するための呼吸補助装置の需要を増加させることにより、高流量鼻カニューレ（HFNC）市場に大きな影響を与えています。さらに、気道の最適な水分補給を維持しながら高流量酸素療法を提供し、侵襲的換気の必要性を低減する能力により、HFNCはCOVID-19患者、特に急性呼吸不全または急性呼吸窮迫症候群（ARDS）を経験している患者の治療に好ましい選択肢となっています。

予測期間中、鼻カニューレセグメントが最大となる見込み

鼻カニューレセグメントが最大のシェアを占めると推定されます。鼻カニューレは、患者の鼻孔に挿入される柔らかい突起と、酸素の流量を調節する専用装置に接続されたチューブで構成されています。高流量と加温・加湿された酸素の組み合わせは、気道の最適な水分補給を維持し、粘膜の炎症を抑え、患者の快適性を向上させる。高流量鼻カニューレ市場は、従来の方法と比較して、酸素療法の実施、患者の転帰の改善、快適性の向上に有効であることから、大きな成長を遂げています。

予測期間中、急性呼吸不全分野のCAGRが最も高くなると予測される

急性呼吸不全分野は、予測期間中に有利な成長が見込まれます。温かく加湿された酸素を正確に調節された流量で供給することで、HFNCsは患者の快適性を向上させ、気道抵抗を減らし、呼吸作業を減少させる。これらの要素は、患者がしばしば呼吸困難や不快感を経験するARFの管理において特に有益です。さらに、HFNC療法はARFの症例によっては侵襲的な人工呼吸の必要性を防ぎ、挿管とその合併症に伴うリスクを軽減することができます。

最大のシェアを占める地域

北米は、呼吸に問題を抱える患者に高流量酸素療法を提供する有効性により、予測期間中最大の市場シェアを占めました。この地域は高度なヘルスケア・インフラを誇り、慢性呼吸器疾患の有病率が高いため、HFNCシステムの需要を牽引しています。さらに、この地域は高齢化が進んでおり、慢性閉塞性肺疾患（COPD）や睡眠時無呼吸症候群のような疾患の発生率が高いことも、HFNC療法の採用をさらに後押ししています。

CAGRが最も高い地域：

アジア太平洋地域は、ライフスタイルの変化に起因して、予測期間中に収益性の高い成長を示すと予想されます。慢性閉塞性肺疾患（COPD）や呼吸器感染症のような疾患の有病率の増加には、汚染レベルの上昇、タバコの消費、高齢化が寄与しており、HFNCのような効果的な呼吸器サポートシステムが必要とされています。さらに、ヘルスケアインフラの改善、ヘルスケアサービスへのアクセスの拡大、医療費の増加は、APACにおける高度な呼吸ケア機器の需要をさらに刺激しています。

無料カスタマイズ提供：

本レポートをご購読のお客様は、以下の無料カスタマイズオプションのいずれかを受けることができます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 用途分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の高流量鼻カニューレ市場：コンポーネント別

• 加湿器
• 鼻カニューレ
• シングル加熱チューブ
• 空気/酸素混合
• その他のコンポーネント

第6章 世界の高流量鼻カニューレ市場：販売チャネル別

• 代理店販売
• 直接販売

第7章 世界の高流量鼻カニューレ市場：用途別

• 急性呼吸不全
• 睡眠時無呼吸
• 一酸化炭素毒性
• 急性呼吸不全
• 気管支拡張症
• 慢性閉塞性肺疾患（COPD）
• その他の用途

第8章 世界の高流量鼻カニューレ市場：エンドユーザー別

• トモシンセシス
• 外来診療センター
• 病院
• 長期ケアセンター
• その他のエンドユーザー

第9章 世界の高流量鼻カニューレ市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイリング

• Becton, Dickinson and Company
• Fisher & Paykel Healthcare Corporation Ltd.
• Flexicare Medical Ltd.
• Great Group Medical Co., Ltd.
• Hamilton Medical AG
• MEK-ICS Co., Ltd.
• Resmed Inc.
• Salter Labs Inc.
• Smiths Medical
• Teijin Pharma Ltd.
• Teleflex, Inc.
• TNI Medical AG
• Vapotherm, Inc.

List of Tables

• Table 1 Global High Flow Nasal Cannula Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
• Table 3 Global High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
• Table 4 Global High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
• Table 5 Global High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
• Table 6 Global High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
• Table 7 Global High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
• Table 8 Global High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 9 Global High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
• Table 10 Global High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
• Table 11 Global High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
• Table 12 Global High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 13 Global High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
• Table 14 Global High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
• Table 15 Global High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 16 Global High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
• Table 17 Global High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 18 Global High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 19 Global High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
• Table 20 Global High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
• Table 21 Global High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
• Table 22 Global High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 23 Global High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
• Table 24 Global High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 25 North America High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
• Table 26 North America High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
• Table 27 North America High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
• Table 28 North America High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
• Table 29 North America High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
• Table 30 North America High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
• Table 31 North America High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
• Table 32 North America High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 33 North America High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
• Table 34 North America High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
• Table 35 North America High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
• Table 36 North America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 37 North America High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
• Table 38 North America High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
• Table 39 North America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 40 North America High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
• Table 41 North America High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 42 North America High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 43 North America High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
• Table 44 North America High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
• Table 45 North America High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
• Table 46 North America High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 47 North America High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
• Table 48 North America High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 49 Europe High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
• Table 50 Europe High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
• Table 51 Europe High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
• Table 52 Europe High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
• Table 53 Europe High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
• Table 54 Europe High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
• Table 55 Europe High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
• Table 56 Europe High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 57 Europe High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
• Table 58 Europe High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
• Table 59 Europe High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
• Table 60 Europe High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 61 Europe High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
• Table 62 Europe High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
• Table 63 Europe High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 64 Europe High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
• Table 65 Europe High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 66 Europe High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 67 Europe High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
• Table 68 Europe High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
• Table 69 Europe High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
• Table 70 Europe High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 71 Europe High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
• Table 72 Europe High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 73 Asia Pacific High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
• Table 74 Asia Pacific High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
• Table 75 Asia Pacific High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
• Table 76 Asia Pacific High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
• Table 77 Asia Pacific High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
• Table 78 Asia Pacific High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
• Table 79 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
• Table 80 Asia Pacific High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 81 Asia Pacific High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
• Table 82 Asia Pacific High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
• Table 83 Asia Pacific High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
• Table 84 Asia Pacific High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 85 Asia Pacific High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
• Table 86 Asia Pacific High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
• Table 87 Asia Pacific High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 88 Asia Pacific High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
• Table 89 Asia Pacific High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 90 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 91 Asia Pacific High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
• Table 92 Asia Pacific High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
• Table 93 Asia Pacific High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
• Table 94 Asia Pacific High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 95 Asia Pacific High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
• Table 96 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 97 South America High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
• Table 98 South America High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
• Table 99 South America High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
• Table 100 South America High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
• Table 101 South America High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
• Table 102 South America High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
• Table 103 South America High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
• Table 104 South America High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 105 South America High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
• Table 106 South America High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
• Table 107 South America High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
• Table 108 South America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 109 South America High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
• Table 110 South America High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
• Table 111 South America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 112 South America High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
• Table 113 South America High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 114 South America High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 115 South America High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
• Table 116 South America High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
• Table 117 South America High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
• Table 118 South America High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 119 South America High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
• Table 120 South America High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 121 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
• Table 122 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
• Table 123 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
• Table 124 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
• Table 125 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
• Table 126 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
• Table 127 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
• Table 128 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 129 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
• Table 130 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
• Table 131 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
• Table 132 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 133 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
• Table 134 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
• Table 135 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
• Table 136 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
• Table 137 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 138 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 139 Middle East & Africa High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
• Table 140 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
• Table 141 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
• Table 142 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 143 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
• Table 144 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global High-flow Nasal Cannula Market is accounted for $7.7 billion in 2023 and is expected to reach $19.27 billion by 2030 growing at a CAGR of 14% during the forecast period. A high-flow nasal cannula is a respiratory therapy device that delivers heated and humidified oxygen at high flow rates through small nasal prongs. This therapy is used to treat patients with acute respiratory failure by providing precise oxygenation levels while offering comfort and reducing the work of breathing. The warmed and humidified gas mixture enhances patient tolerance and mobilization, while the high flow rates help to splint open airways, decrease airway resistance, and potentially reduce the need for invasive mechanical ventilation.

According to the World Health Organization It is estimated that 235 million people worldwide have asthma.

Market Dynamics:

Driver:

Rising prevalence of respiratory disorders

Respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and acute respiratory distress syndrome (ARDS) have been on the rise globally. These conditions often require effective oxygen therapy to alleviate respiratory distress and improve patient outcomes. High-flow nasal cannulas deliver a higher flow rate of oxygen compared to traditional oxygen therapy methods, making them particularly beneficial for patients with respiratory disorders. Moreover, they provide a constant and adjustable supply of oxygen, ensuring adequate oxygenation and reducing the workload on the patient's respiratory system.

Restraint:

High cost

HFNC systems can be relatively expensive compared to traditional oxygen therapy methods, which can pose financial challenges for healthcare providers. The initial investment required to purchase the HFNC system, including the flow generator and heated humidifier, can be substantial. The need for regular maintenance and calibration of the equipment further adds to the financial burden, which in turn limits market growth.

Opportunity:

Technological advancements

Ongoing innovations and improvements in HFNC technology have enhanced its performance, safety, and patient comfort, driving increased adoption and utilization. Innovations in flow generators, heated humidifiers, and nasal cannula design have enhanced the performance and comfort of HFNC therapy. Furthermore, manufacturers have introduced soft, flexible, and anatomically contoured nasal cannulas that enhance patient comfort and reduce skin irritation. These advancements in cannula design also contribute to better oxygen delivery and reduce the risk of nasal trauma.

Threat:

Competition from alternative respiratory support therapies

The high-flow nasal cannula (HFNC) market faces restraints due to competition from alternative respiratory support therapies. Non-invasive ventilation, delivered through devices such as bi-level positive airway pressure (BiPAP) or continuous positive airway pressure (CPAP) provides varying levels of pressure support to assist breathing in patients with respiratory failure. Furthermore, invasive mechanical ventilation, involving end tracheal intubation and mechanical ventilator support, is often required for patients with severe respiratory distress or acute respiratory failure.

Covid-19 Impact

The COVID-19 pandemic has significantly impacted the high-flow nasal cannula (HFNC) market by increasing the demand for respiratory support devices to treat patients with severe respiratory symptoms, particularly those suffering from COVID-19-related respiratory distress. Moreover, due to its ability to deliver high-flow oxygen therapy while maintaining optimal airway hydration and reducing the need for invasive ventilation, HFNC has become a preferred option for treating COVID-19 patients, especially those experiencing acute respiratory failure or acute respiratory distress syndrome (ARDS).

The nasal cannula segment is expected to be the largest during the forecast period

The nasal cannula segment is estimated to hold the largest share. The nasal cannula consists of soft prongs that are inserted into the patient's nostrils, along with tubing connected to a specialized device that regulates the flow of oxygen. The high flow rate, combined with the heated and humidified oxygen, helps maintain optimal airway hydration, reduces mucosal irritation, and improves patient comfort. The high-flow nasal cannula market has experienced significant growth due to its effectiveness in delivering oxygen therapy, improving patient outcomes, and enhancing comfort compared to traditional methods.

The acute respiratory failure segment is expected to have the highest CAGR during the forecast period

The acute respiratory failure segment is anticipated to have lucrative growth during the forecast period. By delivering a precisely regulated flow of warm and humidified oxygen, HFNCs improve patient comfort, reduce airway resistance, and decrease the work of breathing. These factors are particularly beneficial in the management of ARF, where patients often experience respiratory distress and discomfort. Furthermore, HFNC therapy can prevent the need for invasive mechanical ventilation in some ARF cases, thereby reducing the risks associated with intubation and its complications.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to due to its efficacy in delivering high-flow oxygen therapy to patients with respiratory issues. This region boasts advanced healthcare infrastructure and a high prevalence of chronic respiratory diseases, driving the demand for HFNC systems. Additionally, the region's aging population and the incidence of conditions like chronic obstructive pulmonary disease (COPD) and sleep apnea further fuel the adoption of HFNC therapy.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, owing to the lifestyle changes. Rising pollution levels, tobacco consumption, and an aging population contribute to the growing prevalence of conditions like chronic obstructive pulmonary disease (COPD) and respiratory infections, necessitating effective respiratory support systems such as HFNCs. Moreover, improving healthcare infrastructure, expanding access to healthcare services, and increasing healthcare expenditure further stimulate the demand for advanced respiratory care devices in APAC.

Key players in the market

Some of the key players in the High-flow Nasal Cannula Market include Becton, Dickinson and Company, Fisher & Paykel Healthcare Corporation Ltd., Flexicare Medical Ltd., Great Group Medical Co., Ltd., Hamilton Medical AG, MEK-ICS Co., Ltd., Resmed Inc., Salter Labs Inc., Smiths Medical, Teijin Pharma Ltd., Teleflex, Inc., TNI Medical AG and Vapotherm, Inc.

Key Developments:

In January 2024, BD (Becton, Dickinson and Company) and Techcyte announced a strategic collaboration agreement to offer an AI-based algorithm that guides cytologists and pathologists to efficiently and effectively identify evidence of cervical cancer and pre cancer using whole-slide imaging.

In November 2023, Teijin Limited announced that the company has entered into an exclusive license agreement with Ascendis Pharma A/S for the further development and commercialization of TransCon hGH, TransCon PTH, and TransCon CNP for endocrinology rare disease in Japan.

In March 2023, Becton Dickinson and the Agency for Science, Technology and Research have announced an extended research partnership that will focus on deep immune phenotyping of human tissues using spectral flow cytometry panels to bring forth discoveries that can be translated into positive healthcare outcomes.

Components Covered:

• Air Humidifier
• Nasal Cannula
• Single Heated Tube
• Air/Oxygen Blend
• Other Components

Sales Channels Covered:

• Distributor Sales
• Direct Sales

Applications Covered:

• Acute Respiratory Failure
• Sleep Apnea
• Carbon Monoxide Toxicity
• Acute Respiratory Failure
• Bronchiectasis
• Chronic Obstructive Pulmonary Disease (COPD)
• Other Applications

End Users Covered:

• Tomosynthesis
• Ambulatory Care Centers
• Hospitals
• Long-term Care Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global High Flow Nasal Cannula Market, By Component

• 5.1 Introduction
• 5.2 Air Humidifier
• 5.3 Nasal Cannula
• 5.4 Single Heated Tube
• 5.5 Air/Oxygen Blend
• 5.6 Other Components

6 Global High Flow Nasal Cannula Market, By Sales Channel

• 6.1 Introduction
• 6.2 Distributor Sales
• 6.3 Direct Sales

7 Global High Flow Nasal Cannula Market, By Application

• 7.1 Introduction
• 7.2 Acute Respiratory Failure
• 7.3 Sleep Apnea
• 7.4 Carbon Monoxide Toxicity
• 7.5 Acute Respiratory Failure
• 7.6 Bronchiectasis
• 7.7 Chronic Obstructive Pulmonary Disease (COPD)
• 7.8 Other Applications

8 Global High Flow Nasal Cannula Market, By End User

• 8.1 Introduction
• 8.2 Tomosynthesis
• 8.3 Ambulatory Care Centers
• 8.4 Hospitals
• 8.5 Long-term Care Centers
• 8.6 Other End Users

9 Global High Flow Nasal Cannula Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Becton, Dickinson and Company
• 11.2 Fisher & Paykel Healthcare Corporation Ltd.
• 11.3 Flexicare Medical Ltd.
• 11.4 Great Group Medical Co., Ltd.
• 11.5 Hamilton Medical AG
• 11.6 MEK-ICS Co., Ltd.
• 11.7 Resmed Inc.
• 11.8 Salter Labs Inc.
• 11.9 Smiths Medical
• 11.10 Teijin Pharma Ltd.
• 11.11 Teleflex, Inc.
• 11.12 TNI Medical AG
• 11.13 Vapotherm, Inc.